Introduction The dementia experience is not a monolithic phenomenon—and while core
elements of dementia are considered universal—people living with dementia experience the …

When the US Food and Drug Administration used the accelerated approval process to
authorize the use of the antiamyloid drug aducanumab to treat Alzheimer's disease (AD) …

Importance An accurate blood test for Alzheimer disease (AD) could streamline the
diagnostic workup and treatment of AD. Objective To prospectively evaluate a clinically …

Importance Racial and ethnic groups with higher rates of clinical Alzheimer disease (AD) are
underrepresented in studies of AD biomarkers, including amyloid positron emission …

Importance The US aging population is rapidly becoming more racially and ethnically
diverse. Early diagnosis of dementia is a health care priority. Objective To examine the …

Background: Dementia is often underdiagnosed and this problem is more common among
some ethnoracial groups. Objective: The objective of this study was to examine racial and …

Importance Patients with dementia may be at an increased suicide risk. Identifying groups at
greatest risk of suicide would support targeted risk reduction efforts by clinical dementia …

Availability of safe and effective treatmentsfor Alzheimer disease is an urgent challenge
given the global shift toward an older population and increased risk of mild cognitive …

Introduction Receiving a diagnosis of Alzheimer's disease or related dementias (ADRD) can
be a pivotal and stressful period. We examined the risk of suicide in the first year after ADRD …

Importance Although the barriers to dementia care in primary care are well characterized,
primary care practitioner (PCP) perspectives could be used to support the design of values …